When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...
Counterfeit pharmaceuticals jeopardize public health worldwide, often leading to ineffective or dangerous treatments. Enter ...
Andy Studna is an assistant editor for Pharmaceutical Executive and Applied Clinical Trials. He can be reached at [email protected].
In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...
“Etheros represents an investment in a differentiated platform addressing oxidative stress through catalytic antioxidants,” Boyang Wang, founder of Immortal Dragons, said in the press release (1).
Dr. Michelle Sestak joined HORIBA in 2012 after earning a PhD in physics from the University of Toledo. She specialized in spectroscopic ellipsometry for cadmium telluride thin-film solar cells.
Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ proprietary documentation—the validated procedures and quality protocols that ensure ...
Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...
FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...
Facility design should integrate risk mitigation strategies, focusing on contamination prevention and reliable utility ...
FDA announced on Dec. 1, 2025 that it will be providing agency staff with agentic artificial intelligence (AI) capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results